[On the problem of hemostyptic effect of estriolsuccinate within the scope of anticoagulant therapy using coumarin derivatives].
D001779:Blood Coagulation Factors; D001780:Blood Coagulation Tests; D002200:Capillary Resistance / Q000187:drug effects; D003374:Coumarins / Q000009:adverse effects; D004964:Estriol / Q000627:therapeutic use*; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced / Q000188:drug therapy*; D006487:Hemostasis; D006801:Humans; D013386:Succinates / Q000627:therapeutic use; D014812:Vitamin K / Q000627:therapeutic use
D001779:Blood Coagulation Factors; D003374:Coumarins; D013386:Succinates; D014812:Vitamin K; D004964:Estriol
Zur Frage einer hämostyptischen Wirkung von Oestriolsuccinat im Rahmen der Anticoagulantientherapei mit Cumarinderivaten.